Related Experiment Videos
Three-color flow cytometric study on lymphocytes derived from thymic diseases
M Okumura1, Y Fujii, S Miyoshi
1Department of Surgery (E-1), Graduate School of Medicine, Osaka University, Suita-City, Japan. meinosin@surg1.med.osaka-u.ac.jp
The Journal of Surgical Research
|December 12, 2001
Summary
Three-color flow cytometry helps differentiate thymic neoplasms. While CD4(+)CD8(+) double-positive lymphocytes are common in thymomas, their presence alone doesn't confirm diagnosis, aiding differential diagnosis.
Area of Science:
- Immunology
- Pathology
- Flow Cytometry
Background:
- Anterior mediastinal masses originate from diverse pathologies.
- Thymomas often contain CD4(+)CD8(+) double-positive (DP) lymphocytes, previously suggesting diagnostic utility via two-color flow cytometry.
- Other thymic conditions can also exhibit CD4(+)CD8(+) DP lymphocytes, necessitating more refined analysis.
Purpose of the Study:
- To investigate the utility of three-color flow cytometry in characterizing lymphocyte phenotypes within thymic diseases.
- To differentiate thymomas from other thymic neoplasms based on lymphocyte subset analysis.
Main Methods:
- Analysis of 108 thymic specimens including thymomas, carcinomas, lymphomas, and hyperplasias.
- Evaluation of CD3, CD4, and CD8 expression on tumor-associated lymphocytes using three-color flow cytometry.
Main Results:
- A CD4(+)CD8(+) DP subset proportion exceeding 30% was observed in thymomas, lymphomas, and thymic hyperplasias.
- CD3 expression patterns within the DP subset varied between thymomas/hyperplasias and DP-type lymphomas.
- Distinct CD3(+) cell proportions in the CD4(+)CD8(-) subset differentiated thymomas from hyperplasias.
Conclusions:
- The presence of CD4(+)CD8(+) DP lymphocytes alone is not definitive for thymoma diagnosis.
- Three-color flow cytometry provides enhanced characterization of thymic neoplasms with DP subsets.
- This method serves as a valuable ancillary tool for the differential diagnosis of thymic diseases.